Accessibility Menu
Prf Technologies logo

Prf Technologies(NASDAQ) PRFX

Market Cap$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-100%
5 Year-100%
1 Year-87%
1 Month-5%
$0.95
-0.25%
-0.00Today
Prf Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.952026-08-31
Prf Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.58%USD 1.012026-08-24
1 month-4.64%USD 1.002026-07-31
3 month-52.79%USD 2.022026-06-02
Year to date-70.28%USD 3.212025-12-31
1 year-86.85%USD 7.252025-08-29
3 year-99.82%USD 540.002023-09-01
5 year-99.97%USD 3,612.002021-09-01
Since inception-99.99%USD 8,088.002020-09-01

Prf Technologies Financials at a Glance

Market Cap

$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$25.50K

Net Income (TTM)

-$8.42M

EPS (TTM)

-$8.49

P/E Ratio

-0.11

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$0.95

Volume

21,257

Open

$0.96

Previous Close

$0.95

Daily Range

$0.94 - $0.96

52-Week Range

$0.91 - $9.00

Estimated Earnings Date

Jul 2, 2026

PRFX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prf Technologies

PRF Technologies Ltd. is a specialized pharmaceutical company focused on developing innovative treatments for post-surgical pain management. The company is currently advancing its lead product, PRF-110, through pivotal Phase 3 clinical trials aimed at enhancing recovery experiences for patients undergoing bunionectomy and hernia repair procedures.

Products and Services
  • PRF-110: A unique oil-based solution for direct application in surgical incisions
  • Clinical development focused on sustained pain relief post-surgery
  • Research initiatives aimed at expanding the product pipeline
Growth Outlook
  • PRF-110 is undergoing two pivotal Phase 3 trials, indicating strong potential for market entry
  • Increased focus on post-surgical pain management aligns with growing healthcare needs
  • Strategic partnerships may enhance research capabilities and market reach
Financial Highlights
  • Recent quarterly revenue of $17,000, showing a gradual increase from $8,500
  • Cash and short-term investments total $4.14 million, providing operational liquidity
  • Operating expenses for Q4 were $5.06 million, reflecting ongoing investment in R&D
PRF Technologies Ltd. operates in the healthcare sector, specifically within the drug manufacturing industry, and is headquartered in Tel Aviv, Israel. The company has a market capitalization of approximately $80.5 million and is actively trading on the NASDAQ Capital Market. Despite recent financial challenges, including a net loss of $4.84 million in the latest quarter, the company is positioned for potential growth through its innovative product pipeline and strategic focus on pain management solutions. The ongoing clinical trials for PRF-110 represent a critical step toward addressing significant unmet needs in post-surgical care, which may attract investor interest as the company progresses.
AI Generated • Aug 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

7

CEO

Ehud Geller, PhD, MBA

Website

www.painreform.com

Headquarters

Tel Aviv, TA 6744316, IL

PRFX Financials

Key Financial Metrics (TTM)

Gross Margin

-311.76%

Operating Margin

-34772.55%

Net Income Margin

-33000.00%

Return on Equity

-99.08%

Return on Capital

-58.23%

Return on Assets

-70.14%

Earnings Yield

-9.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.04M

Volume

21.26K

Avg. Volume

1.37M

Financials (TTM)

Gross Profit

-$79.50K

Operating Income

-$8.87M

EBITDA

-$7.51M

Operating Cash Flow

-$6.92M

Capital Expenditure

-$3.00K

Free Cash Flow

-$6.93M

Cash & ST Invst.

$4.14M

Total Debt

$21.00K

Prf Technologies Performance Analysis

Prf Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 17,000N/A
Prf Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31N/A
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31100.0%
Prf Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -989.6011.7%
20232023-12-31USD -856.65-13.4%
20242024-12-31USD -160.82-81.2%
20252025-12-31USD -7.47-95.4%
Prf Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-318.3%
Q22025-06-30N/A
Q32025-09-3089.5%
Q42025-12-31-415.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$17.00K

N/A

Gross Profit

-$53.00K

N/A

Gross Margin

-3.12%

N/A

Market Cap

$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$414.39K

N/A

Employees

7

N/A

Net Income

-$4.84M

-446.7%

EBITDA

-$4.24M

-383.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$4.14M

-2.8%

Total Debt

$21.00K

-53.3%

Accounts Receivable

$142.00K

+19.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$21.00K

-76.7%

Return on Assets

-70.14%

N/A

Return on Invested Capital

-92.78%

N/A

Free Cash Flow

-$3.96M

-98.9%

Operating Cash Flow

-$3.96M

-98.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UPCUniverse Pharmaceuticals Inc.
$4.27-6.77%
ELABPMGC Holdings Inc.
$5.03-3.08%
ATXIAvenue Therapeutics, Inc.
$0.52+15.04%
NCELNewcelX Ltd.
$3.29+0.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$14.06+0.06%
NVDANvidia
$217.44-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.33-0.06%
INTCIntel
$88.97-0.01%

Questions About PRFX

What is the current price of Prf Technologies?

Prf Technologies is trading at $0.95 per share.

What is the 52-week range for Prf Technologies?

Over the past 52 weeks, Prf Technologies has traded between $0.91 and $9.00.

How much debt does Prf Technologies have?

As of the most recent reporting period, Prf Technologies reported total debt of $21.00K.

How much cash does Prf Technologies have on hand?

Prf Technologies reported $4.17M in cash and cash equivalents in its most recent financial results.

What is Prf Technologies’s dividend yield?

Prf Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services